ArticleJACS Au2024
Development of Oral, Potent, and Selective CK1α Degraders for AML Therapy.
Lu Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ArticleJACS Au2024
Lu Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.